---
title: Managing Distributors and Importers Under MDR: Contracts and Compliance
description: What distributors and importers must do under MDR Articles 13, 14, and 16 — and what manufacturers must do to enable them. Includes the Article 16 trap.
authors: Tibor Zechmeister, Felix Lenhard
category: Team Building, Operations & Scaling
primary_keyword: managing distributors importers MDR
canonical_url: https://zechmeister-solutions.com/en/blog/managing-distributors-importers-mdr
source: zechmeister-solutions.com
license: All rights reserved. Content may be cited with attribution and a link to the canonical URL.
---

# Managing Distributors and Importers Under MDR: Contracts and Compliance

*By Tibor Zechmeister (EU MDR Expert, Notified Body Lead Auditor) and Felix Lenhard.*

> **Under MDR, distributors and importers are not simply commercial channels — they are economic operators with their own legal obligations. Mismanage the relationship and Article 16 can turn your distributor into a legal manufacturer overnight, inheriting every obligation you thought was yours alone. The contract is the firewall.**

**By Tibor Zechmeister and Felix Lenhard.**

## TL;DR
- MDR Article 13 imposes direct legal obligations on importers: verification checks, labelling with importer details, complaint handling, and traceability records.
- MDR Article 14 imposes direct obligations on distributors: verification checks, storage and transport conditions, and complaint forwarding.
- MDR Article 16 defines a trap: if a distributor or importer changes the intended purpose, modifies the device, or repackages in ways that affect compliance, they become the legal manufacturer.
- Manufacturers must enable distributor and importer compliance through contracts, documentation flow-down, and training — it is not enough to ship the device.
- The best distribution agreement reads like a QMS procedure with commercial terms attached, not a sales contract with a compliance afterthought.

## Why the distributor relationship is a regulatory relationship

Most startups, especially the technically-oriented ones Felix coaches, approach distribution as a commercial problem. Find a good distributor, sign a contract, hand over devices, collect royalties. The legal framework feels like a formality.

Under MDR it is not a formality. Distributors and importers are explicitly defined as economic operators alongside manufacturers and authorised representatives. They carry direct, enforceable obligations under EU law. If they fail those obligations, they can be fined by competent authorities, their shipments can be blocked, and — most painfully for the manufacturer — they can trigger a chain of non-conformities that lands on the manufacturer's next audit.

The flipside is just as important. If you as manufacturer do not provide distributors and importers with what they need to comply — labelling information, instructions, complaint channels, language translations — you are setting them up to fail and exposing yourself. The MDR economic-operator model assumes a flow of information up and down the chain. You have to engineer that flow.

## What MDR actually says

### Article 13 — General obligations of importers

An importer is the natural or legal person established in the EU that places a device from a third country on the EU market. Before placing a device on the market, the importer must verify that:

- The device has been CE marked and the EU declaration of conformity has been drawn up.
- The manufacturer has been identified and an authorised representative has been designated (where required under Article 11).
- The device has been labelled in accordance with the MDR and accompanied by required instructions for use.
- Where applicable, a UDI has been assigned by the manufacturer under Article 27.

Importers must then indicate on the device — or on its packaging or in an accompanying document — their name, registered trade name or registered trademark, registered place of business, and the address at which they can be contacted. They must keep a register of complaints, non-conforming devices, and recalls and withdrawals, and keep the manufacturer and authorised representative informed. They must ensure that while the device is under their responsibility, storage and transport conditions comply with the conditions set by the manufacturer. They must retain documentation for the period required under Article 10(8).

### Article 14 — General obligations of distributors

A distributor is any natural or legal person in the supply chain — other than the manufacturer or the importer — that makes a device available on the market, up until the point of putting into service. Before making a device available, distributors must verify:

- The device bears the CE marking and an EU declaration of conformity has been drawn up.
- The device is accompanied by information supplied by the manufacturer in accordance with Article 10(11).
- For imported devices, the importer has complied with Article 13(3).
- A UDI has been assigned by the manufacturer where applicable.

Distributors must also ensure that storage and transport conditions comply with manufacturer requirements. They must maintain a register of complaints and forward complaints to manufacturer, importer, and authorised representative. When a distributor considers or has reason to believe that a device is not in conformity, they must not make it available until it has been brought into conformity, and they must inform the manufacturer. For serious risks or falsifications, they must inform the competent authority.

### Article 16 — The trap

This is the article every manufacturer and distributor must understand before signing anything. Article 16 provides that a distributor, importer, or other natural or legal person assumes the obligations incumbent on manufacturers if they:

- Make available on the market a device under their own name, registered trade name, or registered trademark (except where the distributor or importer enters into an agreement with the manufacturer under which the manufacturer is identified as such on the label); or
- Change the intended purpose of a device already placed on the market or put into service; or
- Modify a device already placed on the market or put into service in such a way that compliance with the applicable requirements may be affected.

Article 16(2) provides exceptions for certain activities — translating the information supplied by the manufacturer, changing the outer packaging of a device already placed on the market (provided specific conditions are met) — but these exceptions are narrow and require the distributor or importer to operate a QMS covering those activities, to inform the manufacturer and competent authority, and to provide a specimen.

Plain translation: if your distributor rebrands your device as their own, or repackages it in a way that affects compliance, or translates the IFU without meeting the Article 16(2) conditions, they have just become the legal manufacturer. Their insurance, their liability, their regulatory burden.

## A worked example: the rebranded catheter

A small European catheter manufacturer signs a distribution deal with a larger regional partner. The partner asks to apply their own brand to the packaging and to translate the IFU into three additional languages. The manufacturer agrees informally, thinking it helps sell devices faster.

Six months later, a competent authority inspection at the distributor asks the obvious question: whose name is on the label as manufacturer? The distributor's brand is prominent. The actual manufacturer's name is present but in small type. The inspector opens Article 16.

Outcome: the distributor is treated as having assumed manufacturer obligations. They do not have a QMS under EN ISO 13485. They do not have a technical file. They have no PRRC designated under Article 15. The inspector issues a stop-sale order until the situation is clarified.

The manufacturer is pulled into the discussion. They produce the distribution agreement, which mentions branding casually but does not include the Article 16 carve-out language or the "manufacturer identified as such on the label" structure. The issue takes nine weeks to unwind. The distributor terminates the agreement. The manufacturer loses a quarter of revenue.

What the manufacturer should have done: if the distributor's brand appears on the label, the agreement must explicitly identify the manufacturer on the label in accordance with the Article 16(1)(a) exception, and the prominence and formatting must actually support that identification. This is not a drafting trick — it is a design requirement for the label itself.

## The Subtract to Ship playbook for distributor and importer management

### 1. Treat the distribution agreement as a QMS procedure

Your distribution agreement must contain, at minimum:

- Identification of the economic operator role (distributor or importer).
- Acknowledgement of Article 13 or 14 obligations.
- Storage and transport condition flow-down from the manufacturer IFU and device specification.
- Complaint forwarding timelines — typically within 3 to 5 business days of receipt.
- Traceability obligations under Article 25, including lot-location reporting on demand.
- Recall and field safety corrective action cooperation clauses.
- Labelling and packaging restrictions, with explicit Article 16 language if rebranding or translation is in scope.
- Audit rights for the manufacturer to verify compliance.
- Training obligations for distributor personnel handling the device.
- Termination clauses that include device return and lot reconciliation.

This is not a compliance add-on. It is the commercial contract.

### 2. Build a flow-down pack and keep it current

Every distributor should receive and acknowledge a flow-down pack containing: current IFU in all required languages, labelling specification, storage and transport conditions, complaint reporting form, vigilance reporting contact, recall procedure, and a plain-language summary of their Article 13 or 14 obligations. When any of these documents update, the flow-down goes out with a signature-required acknowledgement. Auditors love this trail because it demonstrates the manufacturer enabled compliance rather than assumed it.

### 3. Audit your distributors at a frequency proportionate to risk

Under EN ISO 13485:2016+A11:2021 clause 7.4, suppliers and outsourced processes are re-evaluated based on risk. Distributors are not technically suppliers in the purchasing sense, but the risk framework applies. High-volume distributors or those handling high-risk devices deserve on-site or remote audits annually. Low-volume distributors of low-risk devices can be verified by questionnaire. Document the basis for the audit frequency.

### 4. Spot the Article 16 triggers before the distributor does

Any proposal involving rebranding, repackaging, translation outside manufacturer control, bundling with other products, or modifying intended purpose statements is an Article 16 conversation. Have a pre-written internal decision matrix. Your commercial team must know that "the distributor wants to put their logo on the box" is not a marketing decision — it is a regulatory review gate. Felix has seen deals collapse because this conversation happened six months too late.

### 5. Connect distributor complaint channels into your PMS system

MDR Articles 83 to 86 require post-market surveillance, and Article 87 vigilance reporting. Complaints from distributors and importers are a primary PMS data source. If distributor complaints live in distributor inboxes, you are missing PMS data and breaching clause 8.2.1 on customer feedback. Build a single, low-friction channel — a monitored email address is the minimum — and make it contractual.

### 6. Know your importer's Article 13 timeline burden

Importers must keep records for the full retention period and must be available to competent authorities. A startup with a single importer in the EU that later wants to wind that importer down cannot simply terminate — the importer's obligations persist for the device lifetime plus retention. Plan importer relationships with that tail in mind.

## Reality Check

1. Do your distribution agreements explicitly name the economic operator role under MDR?
2. If a distributor asked to put their logo on your packaging next week, does your team know this is an Article 16 question?
3. Is there a single documented channel from every distributor into your PMS system for complaints?
4. Can you produce evidence that each distributor has received and acknowledged the current IFU and storage conditions?
5. When did you last audit or verify your largest distributor's compliance with Article 14?
6. Does your importer know their Article 13 labelling requirement to include their own name on the device or accompanying documents?
7. Do your agreements give you audit rights and can you actually exercise them?
8. If an importer terminated tomorrow, do you have a successor plan that keeps Article 10(8) records accessible?

## Frequently Asked Questions

**What is the difference between an importer and a distributor under MDR?**
An importer is specifically the EU-established entity that places a device from a third country on the EU market. A distributor is anyone in the supply chain — other than the manufacturer or importer — making the device available up to the point of putting into service. A device imported from outside the EU always has exactly one importer and can have multiple distributors.

**Do I need a different contract for importers and distributors?**
The obligations are different, so the flow-down clauses are different. One template with role-specific sections works well, but you must select the correct role and the correct obligations. A single generic contract is an audit finding waiting to happen.

**Can my authorised representative also be my importer?**
Yes, and this is a common structure for startups with limited EU presence. The roles are defined separately in the MDR, and a single legal entity can hold both — but the obligations of each role apply independently. See our post on [authorised representatives](/blog/authorized-representatives) for the Article 11 detail.

**What happens if my distributor fails to forward a serious incident complaint?**
Under Article 14, failure to forward is a breach by the distributor. But as manufacturer, you are still responsible for Article 87 vigilance reporting. Your PMS system must not rely solely on the distributor forwarding — build redundant channels, including direct end-user complaint paths.

**Is translating the IFU always an Article 16 trigger?**
Translation alone is covered by the Article 16(2) carve-out if the distributor meets the conditions: operate a QMS for that activity, inform manufacturer and competent authority, provide a specimen, and ensure the translation is accurate. Without meeting those conditions, the translator assumes manufacturer obligations. The cleanest structure is for the manufacturer to control translation.

**What does "available on the market" mean in Article 14?**
Under MDR Article 2, making available on the market means any supply of a device for distribution, consumption, or use on the EU market in the course of a commercial activity. It is distinct from "placing on the market," which is the first making available.

## Related reading
- [MDR importers and distributors explained](/blog/mdr-importers-distributors) — the definitional framework underneath this post.
- [Authorised representatives under MDR](/blog/authorized-representatives) — the Article 11 role that often sits alongside the importer role.
- [Distribution strategy for medical devices in Europe](/blog/distribution-strategy-medical-devices-europe) — the commercial strategy layer above the compliance layer.
- [Manufacturer definition under MDR Article 2(30)](/blog/manufacturer-mdr-article-2-30) — what it means to be the legal manufacturer, which Article 16 can transfer.
- [Inventory management for medical devices](/blog/inventory-management-medical-devices) — the traceability backbone that distributor lot reporting depends on.

## Sources
1. Regulation (EU) 2017/745 on medical devices, consolidated text. Articles 2, 10(8), 10(11), 11, 13, 14, 15, 16, 25, 27, 87.
2. EN ISO 13485:2016+A11:2021 — Medical devices — Quality management systems — Requirements for regulatory purposes. Clauses 7.4, 8.2.1.

---

*This post is part of the [Team Building, Operations & Scaling](https://zechmeister-solutions.com/en/blog/category/team-operations) cluster in the [Subtract to Ship: MDR Blog](https://zechmeister-solutions.com/en/blog). For EU MDR certification consulting, see [zechmeister-solutions.com](https://zechmeister-solutions.com).*